Mobile

A Multicenter, Randomized, Placebo-Controlled, Double-Blind, Parallel-Group, Fixed- Dose Study Evaluating the Effect of One Dose of Rimonabant (20 mg/day) on Glycemic Control in Type 2 Diabetic Patien...

Update Il y a 4 ans
Reference: EUCTR2005-001613-17

A Multicenter, Randomized, Placebo-Controlled, Double-Blind, Parallel-Group, Fixed- Dose Study Evaluating the Effect of One Dose of Rimonabant (20 mg/day) on Glycemic Control in Type 2 Diabetic Patients Inadequately Controlled with Insulin

Woman and Man

  • | Country :
    • -
  • | organs :
    • -
  • | Specialty :
    • -

Extract

To assess the effect of rimonabant on HbA1c in patients with type 2 diabetes treated with insulin.

Inclusion criteria

  • Type 2 Diabetic Patients Inadequately Controlled with Insulin

Links